James Investment Research’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1
Closed 457
2023
Q1
$0 Hold
1
﹤0.01% 622
2022
Q4
$0 Hold
1
﹤0.01% 602
2022
Q3
$0 Hold
1
﹤0.01% 540
2022
Q2
$0 Sell
1
-16
-94% -$560 ﹤0.01% 543
2022
Q1
$1K Sell
17
-84
-83% -$2.87K ﹤0.01% 493
2021
Q4
$3K Sell
101
-25
-20% -$814 ﹤0.01% 480
2021
Q3
$4K Sell
126
-509
-80% -$16.3K ﹤0.01% 458
2021
Q2
$19K Buy
+635
New +$20.9K ﹤0.01% 439

Other funds holding OGN

James Investment Research's OGN Position: Q2 2023 in Review

James Investment Research sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 1 share.

James Investment Research first reported a position in OGN in Q2 2021 and held it in 8 quarters. The position peaked at $19K in Q2 2021. 726 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • James Investment Research reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 1 Organon & Co share in Q2 2023.
  • James Investment Research first reported a position in Organon & Co in Q2 2021 and held it in 8 quarters.
  • James Investment Research's Organon & Co position peaked at $19K in Q2 2021.
  • 726 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.